Emperra GmbH E-Health Technologies

Founded in 2008 in Potsdam, Germany, Emperra GmbH specializes in diabetes management technology. Med Schildt is the CEO and founder, bringing prior entrepreneurial experience to the company.Emperra® GmbH specializes in innovative diabetes management solutions, with its flagship product being the ESYSTA product system. Launched to alleviate the burdens of manual diabetes diary management, ESYSTA automates the storage and recording of insulin units and blood glucose readings. This system enhances patient autonomy by providing seamless data management that allows users to access their diabetes information at any time. The primary end users of ESYSTA include diabetes patients and healthcare professionals, such as diabetologists, who utilize the data for more informed treatment decisions.Emperra® GmbH generates revenue through a subscription-based model for its ESYSTA product system, enabling users and healthcare professionals to access advanced diabetes management tools. The company’s revenue model involves partnerships with medical institutions and healthcare providers, allowing for broader distribution and the use of its technology. Transactions typically occur directly between Emperra and its clients, encompassing both healthcare providers and individual consumers who purchase or subscribe to the ESYSTA system. Specific strategies include targeting expansion into new markets across Europe, aiming to launch updated features of the ESYSTA system within the next year.

1. Series B

   Dec 12, 2015

   Amount

   $3.1M

   Investors

   Locked